Allianz Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,300	Closed	-$554K	–	2225
2025 Q1	$554K	Hold	22,300	–	–	﹤0.01%	1846
2024 Q4	$420K	Buy	22,300 +5,600	+34%	+$98.3K	﹤0.01%	1914
2024 Q3	$251K	Buy	+16,700	New	+$286K	﹤0.01%	2031
2017 Q2	–	Sell	-21,100	Closed	-$962K	–	2669
2017 Q1	$962K	Buy	+21,100	New	+$912K	﹤0.01%	2251
2016 Q4	–	Sell	-53,137	Closed	-$1.82M	–	2644
2016 Q3	$1.82M	Buy	+53,137	New	+$2.08M	﹤0.01%	2022
2015 Q2	–	Sell	-214,773	Closed	-$19.1M	–	2474
2015 Q1	$19.1M	Sell	214,773 -54,479	-20%	-$5.53M	0.02%	713
2014 Q4	$23.9M	Buy	269,252 +10,601	+4%	+$1M	0.03%	637
2014 Q3	$24.9M	Buy	258,651 +88,656	+52%	+$8.62M	0.03%	571
2014 Q2	$15.6M	Buy	169,995 +55,110	+48%	+$4.2M	0.02%	636
2014 Q1	$8.04M	Buy	114,885 +17,572	+18%	+$1.2M	0.01%	812
2013 Q4	$5.59M	Sell	97,313 -12,197	-11%	-$641K	0.01%	912
2013 Q3	$5.27M	Sell	109,510 -135,890	-55%	-$4.95M	0.01%	903
2013 Q2	$7.12M	Buy	+245,400	New	+$7.1M	0.01%	751